Heming Nicholas, Elatrous Souheil, Jaber Samir, Dumenil Anne Sylvie, Cousson Joël, Forceville Xavier, Kimmoun Antoine, Trouillet Jean Louis, Fichet Jérôme, Anguel Nadia, Darmon Michael, Martin Claude, Chevret Sylvie, Annane Djillali
General Intensive Care Unit, Raymond Poincaré Hospital, Garches, France.
U1173 Lab Inflammation& Infection, University of Versailles SQY-Paris Saclay - INSERM, Garches, France.
BMJ Open. 2017 Oct 6;7(10):e016736. doi: 10.1136/bmjopen-2017-016736.
To compare the haemodynamic effect of crystalloids and colloids during acute severe hypovolaemic shock.
Exploratory subgroup analysis of a multicentre randomised controlled trial (Colloids Versus Crystalloids for the Resuscitation of the Critically Ill, CRISTAL, ClinicalTrials.gov NCT00318942).
CRISTAL was conducted in intensive care units in Europe, North Africa and Canada.
Current analysis included all patients who had a pulmonary artery catheter in place at randomisation. 220 patients (117 received crystalloids vs 103 colloids) underwent pulmonary artery catheterisation.
Crystalloids versus colloids for fluid resuscitation in hypovolaemic shock.
Haemodynamic data were collected at the time of randomisation and subsequently on days 1, 2, 3, 4, 5, 6 and 7.
Median cumulative volume of fluid administered during the first 7 days was higher in the crystalloids group than in the colloids group (3500 (2000-6000) vs 2500 (1000-4000) mL, p=0.01). Patients in the colloids arm exhibited a lower heart rate over time compared with those allocated to the crystalloids arm (p=0.014). There was no significant difference in Cardiac Index (p=0.053), mean blood pressure (p=0.4), arterial lactates (p=0.9) or global Sequential Organ Failure Assessment score (p=0.3) over time between arms.
During acute severe hypovolaemic shock, patients monitored by a pulmonary artery catheter achieved broadly similar haemodynamic outcomes, using lower volumes of colloids than crystalloids. The heart rate was lower in the colloids arm.
比较急性严重低血容量性休克期间晶体液和胶体液的血流动力学效应。
一项多中心随机对照试验(用于危重症患者复苏的胶体液与晶体液对比研究,CRISTAL,ClinicalTrials.gov NCT00318942)的探索性子组分析。
CRISTAL试验在欧洲、北非和加拿大的重症监护病房进行。
当前分析纳入了所有在随机分组时已放置肺动脉导管的患者。220例患者(117例接受晶体液治疗,103例接受胶体液治疗)接受了肺动脉导管插入术。
低血容量性休克时使用晶体液与胶体液进行液体复苏。
在随机分组时以及随后的第1、2、3、4、5、6和7天收集血流动力学数据。
晶体液组在前7天给予的液体累积中位数高于胶体液组(3500(2000 - 6000)ml对2500(1000 - 4000)ml,p = 0.01)。随着时间推移,胶体液组患者的心率低于晶体液组患者(p = 0.014)。两组之间,心脏指数(p = 0.053)、平均血压(p = 0.4)、动脉血乳酸(p = 0.9)或总体序贯器官衰竭评估评分(p = 0.3)随时间无显著差异。
在急性严重低血容量性休克期间,通过肺动脉导管监测的患者使用较少量的胶体液与晶体液可获得大致相似的血流动力学结果。胶体液组的心率较低。